Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
811.00    3.00 (0.37%)
Bid:
810.00
Ask:
812.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Director/PDMR Shareholding

25 Apr 2018 13:31

RNS Number : 1081M
Savills PLC
25 April 2018
 

SAVILLS PLC (THE "COMPANY")

NOTIFICATION OF INTERESTS OF DIRECTORS/ PDMRs

 

Vesting of Share Awards

 

Awards made on 24 April 2015 over ordinary shares of the Company under the Company's Deferred Share Plans have now become unconditional following the end of their Deferred Period. In satisfaction of the Awards, on 24 April 2018 shares have been transferred to Directors and PDMRs of the Company as follows:-

 

Director / PDMR

Number of Shares Transferred

Number of Shares Disposed

Shareholding following this notification

Shareholding as a % of issued share capital

Beneficial interest under the Deferred Share Plans following this notification

Jeremy Helsby (Director)

79,534

79,534

564,849

0.40

221,104

Simon Hope (PDMR)

31,813

31,813

179,877

0.13

21,225

Chris Lee (PDMR)

27,172

19,343

100,845

0.07

40,665

Christian Mancini (PDMR)

39,767

0

104,224

0.07

30,637

Justin O'Connor (PDMR)

3,313

3,313

0

0.00

138,469*

Mark Ridley (PDMR)

56,335

56,335

140,897

0.10

159,647

Simon Shaw (Director)

58,855

58,855

155,864

0.11

159,598

 

\* The resulting beneficial interest for Justin O'Connor (CEO, Savills Investment Management) includes an award over 55,575 shares made on 20 June 2016 under the Savills Deferred Share Plan whereby 30% of the award vests subject to continued employment in March 2019, with 70% vesting subject to the satisfaction of performance criteria relating to the financial performance of Savills Investment Management, including the performance of funds managed by Savills Investment Management, over the period to 31 December 2018.

 

On 24 April 2018, ordinary shares of the Company have been allotted to Directors and PDMRs of the Company as follows in satisfaction of the partial vesting of Awards made on 24 April 2015 under the Performance Share Plan:-

 

Director/ PDMR

Number of Shares Allotted

Number of Shares Disposed

Shareholding following this notification

Shareholding as a % of issued share capital

Beneficial interest under the Performance Share Plan following this notification

Jeremy Helsby (Director)

61,774

61,774

564,849

0.40

198,677

Simon Hope (PDMR)

28,078

28,078

179,877

0.13

35,038

Chris Lee (PDMR)

14,038

9,867

105,016

0.07

54,740

Mark Ridley (PDMR)

28,078

28,078

140,897

0.10

125,694

Simon Shaw (Director)

39,310

39,310

155,864

0.11

127,947

 

 

The share price on disposal of all shares was 979.3507p per share.

 

25 April 2018

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFMGZDZKGGRZM
Date   Source Headline
1st Jun 202611:29 amRNSTotal Voting Rights
22nd May 202610:09 amRNSDirector/PDMR Shareholding
14th May 202612:41 pmRNSResult of AGM
13th May 20264:16 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Statement
12th May 20263:41 pmRNSDirector/PDMR Shareholding
7th May 20263:39 pmRNSDirector Declaration
29th Apr 20263:04 pmRNSReplacement - Director/PDMR Shareholding
29th Apr 20261:23 pmRNSDirector/PDMR Shareholding
28th Apr 20261:58 pmRNSDirector/PDMR Shareholding
13th Apr 20265:24 pmRNSHolding(s) in Company
13th Apr 20262:10 pmRNSDirector/PDMR Shareholding
7th Apr 20264:03 pmRNSAnnual Report and AGM Notice
1st Apr 202610:00 amRNSTotal Voting Rights
31st Mar 202612:55 pmRNSDirector/PDMR Shareholding
26th Mar 20268:57 amRNSDirector/PDMR Shareholding
24th Mar 202611:02 amRNSDirector/PDMR Shareholding
23rd Mar 20269:27 amRNSDirector/PDMR Shareholding
18th Mar 20263:47 pmRNSDirector/PDMR Shareholding
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
13th Mar 20261:34 pmRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:08 amRNSFinal Results
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
5th Mar 20265:00 pmRNSHolding(s) in Company
2nd Mar 20269:11 amRNSTotal Voting Rights
25th Feb 202611:14 amRNSHolding(s) in Company
11th Feb 20264:07 pmRNSDirector/PDMR Shareholding
4th Feb 20265:29 pmRNSHolding(s) in Company
2nd Feb 20265:32 pmRNSTotal Voting Rights
19th Jan 20268:30 amRNSDirectorship change
15th Jan 20267:00 amRNSYear End Trading Update
13th Jan 20265:40 pmRNSDirector/PDMR Shareholding
13th Jan 202612:59 pmRNSHolding(s) in Company
2nd Jan 20263:00 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
1st Dec 20259:49 amRNSTotal Voting Rights
11th Nov 20254:58 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:32 pmRNSTotal Voting Rights
13th Oct 20251:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.